Cerity Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Sell |
15,943
-644
| -4% | -$13.9K | ﹤0.01% | 2072 |
|
|
2025
Q1 | $276K | Sell |
16,587
-3,872
| -19% | -$64.3K | ﹤0.01% | 2058 |
|
|
2024
Q4 | $349K | Buy |
20,459
+6,173
| +43% | +$105K | ﹤0.01% | 1962 |
|
|
2024
Q3 | $220K | Buy |
+14,286
| New | +$220K | ﹤0.01% | 2260 |
|
|
2024
Q2 | – | Sell |
-12,992
| Closed | -$240K | – | 2220 |
|
|
2024
Q1 | $240K | Buy |
+12,992
| New | +$240K | ﹤0.01% | 1999 |
|
|
2021
Q3 | – | Sell |
-15,664
| Closed | -$382K | – | 684 |
|
|
2021
Q2 | $382K | Sell |
15,664
-5,000
| -24% | -$122K | 0.01% | 519 |
|
|
2021
Q1 | $533K | Buy |
20,664
+15,000
| +265% | +$387K | 0.01% | 438 |
|
|
2020
Q4 | $303K | Buy |
+5,664
| New | +$303K | 0.01% | 515 |
|